P734: Early outcomes from pcfDNA screening at 8-10 weeks gestation for samples with additional findings
Abstract
Historically, prenatal cell-free DNA (pcfDNA) screening has been available starting at 10 weeks’ gestation. Recent advancements have enabled screening as early as 8 weeks gestation (8w0d–9w6d). This study evaluates early pregnancy outcomes associated with “Additional Findings” results in pcfDNA samples collected during this earlier gestational window.
Fields of Study & Subjects
Prenatal Screening and Diagnostics
Genomics and Rare Diseases
Maternal Mental Health During Pregnancy and Postpartum
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 104226–104226
- Publication date
- 1 January 2026
- Language
- EN